{"gene":"PITPNA","run_date":"2026-04-28T19:45:44","timeline":{"discoveries":[{"year":2023,"finding":"PITPNA stimulates phosphatidylinositol (PtdIns) 4-OH kinase activity to produce PtdIns-4-phosphate (PtdIns-4-P) in the trans-Golgi network, which promotes insulin granule maturation and docking. Conditional deletion of Pitpna in beta-cells causes hyperglycemia by reducing glucose-stimulated insulin secretion and pancreatic beta-cell mass. PITPNA silencing in human islets impairs PtdIns-4-P synthesis, insulin granule maturation and docking, proinsulin processing, and causes ER stress.","method":"Conditional knockout mouse model (Ins-Cre, Pitpnaflox/flox), siRNA silencing in human islets, insulin secretion assays, PtdIns-4-P measurement, electron microscopy of granule docking, proinsulin processing assays, ER stress markers, restoration-of-function experiments in T2D human islets","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (KO mouse, human islet KD, lipid biochemistry, secretion assays, EM) in a single rigorous study with functional rescue","pmids":["37460527"],"is_preprint":false},{"year":2020,"finding":"PDE10A inhibition in DMD zebrafish and DMD patient-derived myoblasts reduces PITPNA expression, suggesting PITPNA acts downstream of PDE10A signaling in the context of muscular dystrophy modification.","method":"Morpholino knockdown of pde10a in sapje-like zebrafish, PDE10A inhibitor treatment, birefringence assay, locomotion and survival assessment, PITPNA expression measurement by qPCR in zebrafish and human myoblasts","journal":"Molecular therapy","confidence":"Medium","confidence_rationale":"Tier 2 — genetic (morpholino) and pharmacological reduction of upstream regulator with downstream PITPNA expression readout, but mechanistic link is correlative","pmids":["33221436"],"is_preprint":false},{"year":1994,"finding":"The human phosphatidylinositol transfer protein gene (PITPNA/PITPN) shares sequence and functional homology with the Drosophila retinal degeneration B gene (rdgB), and was mapped to human chromosome 17p13.3 and mouse chromosome 11.","method":"Chromosomal mapping (cytogenetics), sequence homology analysis","journal":"Cytogenetics and cell genetics","confidence":"Medium","confidence_rationale":"Tier 2 — direct chromosomal mapping with functional homology annotation to rdgB, single study","pmids":["7914867"],"is_preprint":false}],"current_model":"PITPNA (phosphatidylinositol transfer protein alpha) stimulates phosphatidylinositol 4-OH kinase to generate PtdIns-4-phosphate at the trans-Golgi network, a lipid product required for insulin granule maturation, docking, and glucose-stimulated insulin secretion in pancreatic beta-cells; it shares ancestral functional homology with the Drosophila rdgB protein and its expression is regulated downstream of PDE10A signaling in the context of muscular dystrophy."},"narrative":{"teleology":[{"year":1994,"claim":"Establishing PITPNA's evolutionary context and genomic position resolved its identity as the human ortholog of Drosophila rdgB, a phospholipid transfer gene linked to retinal degeneration.","evidence":"Chromosomal mapping and sequence homology analysis placed PITPNA at 17p13.3 and demonstrated functional conservation with rdgB","pmids":["7914867"],"confidence":"Medium","gaps":["No direct functional assay performed for human PITPNA at the time","Physiological role in mammalian tissues not addressed"]},{"year":2020,"claim":"Linking PITPNA expression to PDE10A signaling in muscular dystrophy models suggested a broader role for PITPNA beyond lipid transfer, though the mechanistic connection remained correlative.","evidence":"PDE10A morpholino knockdown and pharmacological inhibition in DMD zebrafish and patient-derived myoblasts with qPCR readout of PITPNA expression","pmids":["33221436"],"confidence":"Medium","gaps":["Relationship between PDE10A and PITPNA is correlative; no direct regulatory mechanism established","Functional consequence of reduced PITPNA in dystrophic muscle not tested","No PITPNA loss-of-function performed in the muscular dystrophy context"]},{"year":2023,"claim":"Defining PITPNA's lipid kinase-stimulatory function at the trans-Golgi network established it as a critical regulator of PtdIns-4-P–dependent insulin granule biogenesis, docking, and secretion, directly linking its loss to hyperglycemia and beta-cell failure.","evidence":"Conditional beta-cell knockout mouse, siRNA in human islets, PtdIns-4-P quantification, electron microscopy of granule docking, proinsulin processing and ER stress assays, functional rescue in T2D islets","pmids":["37460527"],"confidence":"High","gaps":["Structural basis of PITPNA stimulation of PtdIns 4-OH kinase not resolved","Whether PITPNA plays analogous secretory roles in other endocrine or exocrine cell types is untested","Contribution of PITPNA to type 2 diabetes pathogenesis in human patients not established genetically"]},{"year":null,"claim":"How PITPNA physically engages and activates PtdIns 4-OH kinase at the trans-Golgi membrane, and whether PITPNA dysfunction contributes to human diabetes susceptibility, remain open questions.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of the PITPNA–PtdIns 4-kinase interaction","No human genetic evidence linking PITPNA variants to diabetes","Role in non-beta-cell secretory pathways unexplored"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[0,2]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[0]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0]}],"complexes":[],"partners":["PDE10A"],"other_free_text":[]},"mechanistic_narrative":"PITPNA (phosphatidylinositol transfer protein alpha) stimulates phosphatidylinositol 4-OH kinase activity to generate phosphatidylinositol-4-phosphate (PtdIns-4-P) at the trans-Golgi network, thereby promoting insulin granule maturation, docking, proinsulin processing, and glucose-stimulated insulin secretion in pancreatic beta cells [PMID:37460527]. Conditional deletion of Pitpna in mouse beta cells causes hyperglycemia due to reduced insulin secretion and decreased beta-cell mass, while PITPNA silencing in human islets impairs PtdIns-4-P synthesis and induces ER stress [PMID:37460527]. PITPNA shares ancestral functional homology with the Drosophila retinal degeneration B (rdgB) gene and maps to human chromosome 17p13.3 [PMID:7914867]."},"prefetch_data":{"uniprot":{"accession":"Q00169","full_name":"Phosphatidylinositol transfer protein alpha isoform","aliases":[],"length_aa":270,"mass_kda":31.8,"function":"Catalyzes the transfer of phosphatidylinositol (PI) and phosphatidylcholine (PC) between membranes (PubMed:10531358, PubMed:14962392, PubMed:15522822, PubMed:18636990, PubMed:22822086). Shows a preference for PI and PC containing shorter saturated or monosaturated acyl chains at the sn-1 and sn-2 positions (PubMed:15522822, PubMed:22822086). Preference order for PC is C16:1 > C16:0 > C18:1 > C18:0 > C20:4 and for PI is C16:1 > C16:0 > C18:1 > C18:0 > C20:4 > C20:3 (PubMed:22822086)","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q00169/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PITPNA","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PITPNA","total_profiled":1310},"omim":[{"mim_id":"613215","title":"CHROMOSOME 17p13.3, CENTROMERIC, DUPLICATION SYNDROME","url":"https://www.omim.org/entry/613215"},{"mim_id":"607432","title":"LISSENCEPHALY 1; LIS1","url":"https://www.omim.org/entry/607432"},{"mim_id":"605066","title":"TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, EPSILON ISOFORM; YWHAE","url":"https://www.omim.org/entry/605066"},{"mim_id":"600174","title":"PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, ALPHA; PITPNA","url":"https://www.omim.org/entry/600174"},{"mim_id":"247200","title":"MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS","url":"https://www.omim.org/entry/247200"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/PITPNA"},"hgnc":{"alias_symbol":["VIB1A"],"prev_symbol":["PITPN"]},"alphafold":{"accession":"Q00169","domains":[{"cath_id":"3.30.530.20","chopping":"2-38_91-252","consensus_level":"high","plddt":96.3781,"start":2,"end":252}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q00169","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q00169-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q00169-F1-predicted_aligned_error_v6.png","plddt_mean":95.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PITPNA","jax_strain_url":"https://www.jax.org/strain/search?query=PITPNA"},"sequence":{"accession":"Q00169","fasta_url":"https://rest.uniprot.org/uniprotkb/Q00169.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q00169/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q00169"}},"corpus_meta":[{"pmid":"32871048","id":"PMC_32871048","title":"LncRNA PITPNA-AS1 boosts the proliferation and migration of lung squamous cell carcinoma cells by recruiting TAF15 to stabilize HMGB3 mRNA.","date":"2020","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32871048","citation_count":41,"is_preprint":false},{"pmid":"31700026","id":"PMC_31700026","title":"PITPNA-AS1 abrogates the inhibition of miR-876-5p on WNT5A to facilitate hepatocellular carcinoma progression.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/31700026","citation_count":27,"is_preprint":false},{"pmid":"32460193","id":"PMC_32460193","title":"Long noncoding RNA PITPNA-AS1 promotes cervical cancer progression through regulating the cell cycle and apoptosis by targeting the miR-876-5p/c-MET axis.","date":"2020","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/32460193","citation_count":27,"is_preprint":false},{"pmid":"34353336","id":"PMC_34353336","title":"MYBL2-induced PITPNA-AS1 upregulates SIK2 to exert oncogenic function in triple-negative breast cancer through miR-520d-5p and DDX54.","date":"2021","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34353336","citation_count":17,"is_preprint":false},{"pmid":"34470587","id":"PMC_34470587","title":"LncRNA PITPNA-AS1 stimulates cell proliferation and suppresses cell apoptosis in glioblastoma via targeting miR-223-3p/EGFR axis and activating PI3K/AKT signaling pathway.","date":"2021","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/34470587","citation_count":17,"is_preprint":false},{"pmid":"33221436","id":"PMC_33221436","title":"PDE10A Inhibition Reduces the Manifestation of Pathology in DMD Zebrafish and Represses the Genetic Modifier PITPNA.","date":"2020","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33221436","citation_count":16,"is_preprint":false},{"pmid":"37460527","id":"PMC_37460527","title":"Restoration of PITPNA in Type 2 diabetic human islets reverses pancreatic beta-cell dysfunction.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37460527","citation_count":14,"is_preprint":false},{"pmid":"33312000","id":"PMC_33312000","title":"Long Non-Coding RNA PITPNA-AS1 Accelerates the Progression of Colorectal Cancer Through miR-129-5p/HMGB1 Axis.","date":"2020","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/33312000","citation_count":14,"is_preprint":false},{"pmid":"35578599","id":"PMC_35578599","title":"PITPNA-AS1/miR-98-5p to Mediate the Cisplatin Resistance of Gastric Cancer.","date":"2022","source":"Journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35578599","citation_count":13,"is_preprint":false},{"pmid":"34055841","id":"PMC_34055841","title":"LncRNA PITPNA-AS1 as a Potential Diagnostic Marker and Therapeutic Target Promotes Hepatocellular Carcinoma Progression via Modulating miR-448/ROCK1 Axis.","date":"2021","source":"Frontiers in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34055841","citation_count":11,"is_preprint":false},{"pmid":"33495838","id":"PMC_33495838","title":"Long non‑coding RNA PITPNA‑AS1 silencing suppresses proliferation, metastasis and epithelial‑mesenchymal transition in non‑small cell lung cancer cells by targeting microRNA‑32‑5p.","date":"2021","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/33495838","citation_count":11,"is_preprint":false},{"pmid":"35588441","id":"PMC_35588441","title":"LncRNA PITPNA-AS1/miR-223-3p/PTN axis regulates malignant progression and stemness in lung squamous cell carcinoma.","date":"2022","source":"Journal of clinical laboratory analysis","url":"https://pubmed.ncbi.nlm.nih.gov/35588441","citation_count":10,"is_preprint":false},{"pmid":"7914867","id":"PMC_7914867","title":"Localization of the gene encoding human phosphatidylinositol transfer protein (PITPN) to 17p13.3: a gene showing homology to the Drosophila retinal degeneration B gene (rdgB).","date":"1994","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7914867","citation_count":9,"is_preprint":false},{"pmid":"34496348","id":"PMC_34496348","title":"LncRNA PITPNA-AS1 promotes gastric cancer by increasing SOX4 expression via inhibition of miR-92a-3p.","date":"2021","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/34496348","citation_count":8,"is_preprint":false},{"pmid":"37253627","id":"PMC_37253627","title":"lncRNA PITPNA-AS1 promotes cell proliferation and metastasis in hepatocellular carcinoma by upregulating PDGFD.","date":"2023","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/37253627","citation_count":6,"is_preprint":false},{"pmid":"33706585","id":"PMC_33706585","title":"Long non-coding RNA PITPNA-AS1 regulates UNC5B expression in papillary thyroid cancer via sponging miR-129-5p.","date":"2021","source":"The International journal of biological markers","url":"https://pubmed.ncbi.nlm.nih.gov/33706585","citation_count":5,"is_preprint":false},{"pmid":"40342419","id":"PMC_40342419","title":"Diagnostic value of exosome-derived lncRNA PITPNA-AS1 in lung cancer.","date":"2025","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/40342419","citation_count":4,"is_preprint":false},{"pmid":"39003446","id":"PMC_39003446","title":"LncRNA PITPNA-AS1 mediates the diagnostic potential of miR-129-5p in prostate cancer.","date":"2024","source":"BMC urology","url":"https://pubmed.ncbi.nlm.nih.gov/39003446","citation_count":3,"is_preprint":false},{"pmid":"38753591","id":"PMC_38753591","title":"PITPNA-AS1 Inhibits Cell Proliferation and Migration in Ovarian Cancer by Regulating the MIR-223-3p/RHOB Axis.","date":"2024","source":"Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion","url":"https://pubmed.ncbi.nlm.nih.gov/38753591","citation_count":1,"is_preprint":false},{"pmid":"33576440","id":"PMC_33576440","title":"[Corrigendum] Long non‑coding RNA PITPNA‑AS1 silencing suppresses proliferation, metastasis and epithelial‑mesenchymal transition in non‑small cell lung cancer cells by targeting microRNA‑32‑5p.","date":"2021","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/33576440","citation_count":1,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":11673,"output_tokens":917,"usd":0.024387},"stage2":{"model":"claude-opus-4-6","input_tokens":4098,"output_tokens":2584,"usd":0.127635},"total_usd":0.152022,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2023,\n      \"finding\": \"PITPNA stimulates phosphatidylinositol (PtdIns) 4-OH kinase activity to produce PtdIns-4-phosphate (PtdIns-4-P) in the trans-Golgi network, which promotes insulin granule maturation and docking. Conditional deletion of Pitpna in beta-cells causes hyperglycemia by reducing glucose-stimulated insulin secretion and pancreatic beta-cell mass. PITPNA silencing in human islets impairs PtdIns-4-P synthesis, insulin granule maturation and docking, proinsulin processing, and causes ER stress.\",\n      \"method\": \"Conditional knockout mouse model (Ins-Cre, Pitpnaflox/flox), siRNA silencing in human islets, insulin secretion assays, PtdIns-4-P measurement, electron microscopy of granule docking, proinsulin processing assays, ER stress markers, restoration-of-function experiments in T2D human islets\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (KO mouse, human islet KD, lipid biochemistry, secretion assays, EM) in a single rigorous study with functional rescue\",\n      \"pmids\": [\"37460527\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PDE10A inhibition in DMD zebrafish and DMD patient-derived myoblasts reduces PITPNA expression, suggesting PITPNA acts downstream of PDE10A signaling in the context of muscular dystrophy modification.\",\n      \"method\": \"Morpholino knockdown of pde10a in sapje-like zebrafish, PDE10A inhibitor treatment, birefringence assay, locomotion and survival assessment, PITPNA expression measurement by qPCR in zebrafish and human myoblasts\",\n      \"journal\": \"Molecular therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic (morpholino) and pharmacological reduction of upstream regulator with downstream PITPNA expression readout, but mechanistic link is correlative\",\n      \"pmids\": [\"33221436\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The human phosphatidylinositol transfer protein gene (PITPNA/PITPN) shares sequence and functional homology with the Drosophila retinal degeneration B gene (rdgB), and was mapped to human chromosome 17p13.3 and mouse chromosome 11.\",\n      \"method\": \"Chromosomal mapping (cytogenetics), sequence homology analysis\",\n      \"journal\": \"Cytogenetics and cell genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct chromosomal mapping with functional homology annotation to rdgB, single study\",\n      \"pmids\": [\"7914867\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PITPNA (phosphatidylinositol transfer protein alpha) stimulates phosphatidylinositol 4-OH kinase to generate PtdIns-4-phosphate at the trans-Golgi network, a lipid product required for insulin granule maturation, docking, and glucose-stimulated insulin secretion in pancreatic beta-cells; it shares ancestral functional homology with the Drosophila rdgB protein and its expression is regulated downstream of PDE10A signaling in the context of muscular dystrophy.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PITPNA (phosphatidylinositol transfer protein alpha) stimulates phosphatidylinositol 4-OH kinase activity to generate phosphatidylinositol-4-phosphate (PtdIns-4-P) at the trans-Golgi network, thereby promoting insulin granule maturation, docking, proinsulin processing, and glucose-stimulated insulin secretion in pancreatic beta cells [PMID:37460527]. Conditional deletion of Pitpna in mouse beta cells causes hyperglycemia due to reduced insulin secretion and decreased beta-cell mass, while PITPNA silencing in human islets impairs PtdIns-4-P synthesis and induces ER stress [PMID:37460527]. PITPNA shares ancestral functional homology with the Drosophila retinal degeneration B (rdgB) gene and maps to human chromosome 17p13.3 [PMID:7914867].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Establishing PITPNA's evolutionary context and genomic position resolved its identity as the human ortholog of Drosophila rdgB, a phospholipid transfer gene linked to retinal degeneration.\",\n      \"evidence\": \"Chromosomal mapping and sequence homology analysis placed PITPNA at 17p13.3 and demonstrated functional conservation with rdgB\",\n      \"pmids\": [\"7914867\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No direct functional assay performed for human PITPNA at the time\",\n        \"Physiological role in mammalian tissues not addressed\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Linking PITPNA expression to PDE10A signaling in muscular dystrophy models suggested a broader role for PITPNA beyond lipid transfer, though the mechanistic connection remained correlative.\",\n      \"evidence\": \"PDE10A morpholino knockdown and pharmacological inhibition in DMD zebrafish and patient-derived myoblasts with qPCR readout of PITPNA expression\",\n      \"pmids\": [\"33221436\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Relationship between PDE10A and PITPNA is correlative; no direct regulatory mechanism established\",\n        \"Functional consequence of reduced PITPNA in dystrophic muscle not tested\",\n        \"No PITPNA loss-of-function performed in the muscular dystrophy context\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defining PITPNA's lipid kinase-stimulatory function at the trans-Golgi network established it as a critical regulator of PtdIns-4-P–dependent insulin granule biogenesis, docking, and secretion, directly linking its loss to hyperglycemia and beta-cell failure.\",\n      \"evidence\": \"Conditional beta-cell knockout mouse, siRNA in human islets, PtdIns-4-P quantification, electron microscopy of granule docking, proinsulin processing and ER stress assays, functional rescue in T2D islets\",\n      \"pmids\": [\"37460527\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of PITPNA stimulation of PtdIns 4-OH kinase not resolved\",\n        \"Whether PITPNA plays analogous secretory roles in other endocrine or exocrine cell types is untested\",\n        \"Contribution of PITPNA to type 2 diabetes pathogenesis in human patients not established genetically\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How PITPNA physically engages and activates PtdIns 4-OH kinase at the trans-Golgi membrane, and whether PITPNA dysfunction contributes to human diabetes susceptibility, remain open questions.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structural model of the PITPNA–PtdIns 4-kinase interaction\",\n        \"No human genetic evidence linking PITPNA variants to diabetes\",\n        \"Role in non-beta-cell secretory pathways unexplored\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [0, 2]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0009609507\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"PDE10A\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\nWait, I need to fix the pathway term_ids. Let me correct:\n\n```json\n{\n  \"mechanistic_narrative\": \"PITPNA (phosphatidylinositol transfer protein alpha) stimulates phosphatidylinositol 4-OH kinase activity to generate phosphatidylinositol-4-phosphate (PtdIns-4-P) at the trans-Golgi network, thereby promoting insulin granule maturation, docking, proinsulin processing, and glucose-stimulated insulin secretion in pancreatic beta cells [PMID:37460527]. Conditional deletion of Pitpna in mouse beta cells causes hyperglycemia due to reduced insulin secretion and decreased beta-cell mass, while PITPNA silencing in human islets impairs PtdIns-4-P synthesis and induces ER stress [PMID:37460527]. PITPNA shares ancestral functional homology with the Drosophila retinal degeneration B (rdgB) gene and maps to human chromosome 17p13.3 [PMID:7914867].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Establishing PITPNA's evolutionary context and genomic position resolved its identity as the human ortholog of Drosophila rdgB, a phospholipid transfer gene linked to retinal degeneration.\",\n      \"evidence\": \"Chromosomal mapping and sequence homology analysis placed PITPNA at 17p13.3 and demonstrated functional conservation with rdgB\",\n      \"pmids\": [\"7914867\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No direct functional assay performed for human PITPNA at the time\",\n        \"Physiological role in mammalian tissues not addressed\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Linking PITPNA expression to PDE10A signaling in muscular dystrophy models suggested a broader role for PITPNA beyond lipid transfer, though the mechanistic connection remained correlative.\",\n      \"evidence\": \"PDE10A morpholino knockdown and pharmacological inhibition in DMD zebrafish and patient-derived myoblasts with qPCR readout of PITPNA expression\",\n      \"pmids\": [\"33221436\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Relationship between PDE10A and PITPNA is correlative; no direct regulatory mechanism established\",\n        \"Functional consequence of reduced PITPNA in dystrophic muscle not tested\",\n        \"No PITPNA loss-of-function performed in the muscular dystrophy context\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defining PITPNA's lipid kinase-stimulatory function at the trans-Golgi network established it as a critical regulator of PtdIns-4-P-dependent insulin granule biogenesis, docking, and secretion, directly linking its loss to hyperglycemia and beta-cell failure.\",\n      \"evidence\": \"Conditional beta-cell knockout mouse, siRNA in human islets, PtdIns-4-P quantification, electron microscopy of granule docking, proinsulin processing and ER stress assays, functional rescue in T2D islets\",\n      \"pmids\": [\"37460527\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of PITPNA stimulation of PtdIns 4-OH kinase not resolved\",\n        \"Whether PITPNA plays analogous secretory roles in other endocrine or exocrine cell types is untested\",\n        \"Contribution of PITPNA to type 2 diabetes pathogenesis in human patients not established genetically\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How PITPNA physically engages and activates PtdIns 4-OH kinase at the trans-Golgi membrane, and whether PITPNA dysfunction contributes to human diabetes susceptibility, remain open questions.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structural model of the PITPNA-PtdIns 4-kinase interaction\",\n        \"No human genetic evidence linking PITPNA variants to diabetes\",\n        \"Role in non-beta-cell secretory pathways unexplored\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [0, 2]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}\n```"}